Cardiogen is a synthetic peptide bioregulator associated with the cardiovascular system. It is made from a short four–amino acid sequence: Ala-Glu-Asp-Arg --- Also written as AEDR Cardiogen belongs to the Khavinson-style short peptide bioregulator category and is generally discussed as a targeted synthetic peptide for heart and vascular tissue. It is better understood as a cardiovascular regulatory peptide that may influence cellular signaling, gene expression, tissue maintenance, and repair-related pathways within heart and vascular tissue. ❤️ What is the main focus behind Cardiogen? Cardiogen is cardiovascular regulation. That means it is studied for its potential role in helping heart and vascular cells maintain healthier function under stress, aging, low oxygen conditions, or metabolic strain. Cardiogen is often discussed in connection with: · Heart muscle resilience · Myocardial integrity · Cardiovascular aging · Vascular endothelial support · Oxidative stress · Hypoxia-related stress · Tissue remodeling research · Cellular repair signaling The key point is this: Cardiogen does not “push” the heart. It helps support the heart’s cellular regulation system. That is what makes it different from a conventional cardiac medication or stimulant-like compound. 🔬 How is Cardiogen believed or thought to work? Research around short-chain peptide bioregulators suggests they may influence tissue-specific gene expression, protein synthesis, and cellular repair signaling. Cardiogen is believed to work at the cellular level rather than by creating an immediate drug-like effect. For Cardiogen specifically, the main areas of interest include: 1. Heart muscle support- Cardiogen is commonly discussed in relation to cardiomyocytes, which are the muscle cells of the heart. 2. Tissue remodeling and fibrosis research - One major area of cardiovascular research involves tissue remodeling. When the heart is under chronic stress or injury, normal functional tissue can be replaced by stiff, less functional scar-like tissue. Cardiogen is studied for its possible influence on signaling pathways connected to fibrosis and tissue remodeling.

Think of Bronchogen as a software update for your respiratory system. Not a stimulant. Not a temporary breathing hack. Not something designed to simply “open the airways” for a few hours. Bronchogen is a short peptide built from just four amino acids connected like four links in a chain: alanine, glutamic acid, aspartic acid and leucine. Scientists shorten that exact sequence to Ala–Glu–Asp–Leu, or A–E–D–L. It is the complete four-part chain working as one signal—not four separate ingredients—that gives Bronchogen its identity. Bronchogen belongs to the Khavinson peptide family, a group of ultra-short bioregulator peptides studied for organ-specific signaling. In plain English, Bronchogen is designed to communicate with the respiratory system—especially the lungs, bronchi and airway tissue. It has been studied for its potential role in airway lining repair, mucus balance, cilia function, localized respiratory inflammation, surfactant support and local immune defense inside the respiratory tract. How Does It Work? The “Airway Repair Code” Effect Bronchogen is not about forcing the lungs to work harder. It is about helping the lung tissue remember how to repair, organize and defend itself. Think of your respiratory system like a tunnel network. The airway lining is the wall of that tunnel. The mucus layer is the trap system. The cilia are the cleanup crew. The immune cells are the patrol units. The alveoli are the deep exchange chambers where breathing actually matters. Over time, things like pollution, smoking, vaping, respiratory illness, chronic inflammation or environmental stress can irritate and damage that system. The lining can become weaker. Mucus can become thicker or overproduced. Cilia may not clear debris as efficiently. Inflammation can stay switched on too long. The lungs may lose some of their smooth, elastic feel. Bronchogen is studied as a signal that may help restore order inside that respiratory environment. In simple terms, it tells the system:

Think of Pinalex as a support signal for the eyes, retina and optic nerve. Not an eye drop. Not a lubricant. Not a vitamin for temporary eye comfort. Pinalex is a short peptide built from just three amino acids connected like three links in a chain: glutamic acid, aspartic acid and arginine. Scientists shorten that exact sequence to Glu–Asp–Arg, or E–D–R. That sequence may look familiar because EDR is also the same amino acid sequence associated with Pinealon, the brain-focused synthetic cytogen. But with Pinalex, the conversation shifts toward the visual system — especially retinal tissue, ocular structure and optic nerve support. It is the complete three-part chain working as one signal—not three separate ingredients—that gives Pinalex its identity. Pinalex belongs to the synthetic cytogen side of the bioregulator world, where ultra-short peptide chains are studied for tissue-specific signaling and gene-expression support. In plain English, Pinalex is aimed at the eye’s deeper repair systems — not just the surface of the eye, but the retina, photoreceptors, retinal blood flow and nerve pathways involved in vision. How Does It Work? The “Visual Circuit Repair” Effect Pinalex is not about making the eyes feel wet for a few hours. It is about supporting the visual system where the real work happens. Think of your eyes like a high-resolution camera connected to a live electrical network. The retina is the sensor. The rods and cones are the pixels. The optic nerve is the cable. The retinal blood vessels are the power supply. The antioxidant systems are the surge protectors. Over time, aging, oxidative stress, blue light exposure, vascular strain, inflammation or pressure inside the eye can stress that system. Photoreceptors may become more vulnerable. Retinal cells may lose efficiency. Blood flow may become less resilient. Oxidative damage can build up. The optic nerve pathway may face structural pressure. Pinalex is studied as a signal that may help support the repair and protection systems inside that visual network.

Summer Session #1 has officially closed and achieved its objective. Thank you again to everyone who participated and helped move the first session across the finish line. With Session #1 now complete, Summer Session #2 is officially open. 🌴 NEW FOR SESSION #2 📅 21 DAY SUBMISSION CYCLE Session Start Date:June 19, 2026 Vendor Submission Date:July 10, 2026 The objective is simple. Members may submit participation requests at any time during the active cycle. At the conclusion of the 21-day period, the session closes and the consolidated vendor order is submitted. No waiting for a Dollar threshold. No uncertainty regarding submission timing. Just a defined participation window and a defined submission date. Session #2 Continues To Support: • Full Kits • Half Kit Pairings • Member Requested Products • Consolidated Shipping Structure Any Half Kit requests that remained unpaired during Session #1 have automatically rolled forward into Session #2. A new Session #2 Board has been posted and will be updated periodically throughout the cycle. As always, thank you for the continued participation, feedback, and support as these seasonal sessions continue to evolve. 🌴 Your Body. Your Code. 🌴